{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 461936124
| IUPAC_name = 9-[3-(isopropylamino)propyl]-9''H''-fluorene-9-carboxamide
| image = Indecainide structure.svg
| width = 180
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 74517-78-5
| CAS_supplemental = <br />{{CAS|73681-12-6}} (HCl)
| ATC_prefix = none
| PubChem = 52194
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00192
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 47194
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3AZF20DM1T 
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04521
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201242
<!--Chemical data-->
| C=20 | H=24 | N=2 | O=1
| molecular_weight = 308.42 g/mol
| smiles = O=C(N)C3(c1ccccc1c2c3cccc2)CCCNC(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UCEWGESNIULAGX-UHFFFAOYSA-N
}}

'''Indecainide''' ([[International Nonproprietary Name|INN]], trade name '''Decabid''') is a class Ic [[antiarrhythmic agent]]. Developed and marketed by [[Eli Lilly and Company|Lilly]], it has now been discontinued.

==References==
{{Reflist|2}}

==External links==
* FDA drug details [http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails]

{{Antiarrhythmic agents}}

[[Category:Antiarrhythmic agents]]
[[Category:Fluorenes]]
[[Category:Carboxamides]]


{{cardiovascular-drug-stub}}